Investing Ideas
/
Taiwanese Pharmaceuticals & Biotech High And Sustainable

Taiwanese Pharmaceuticals & Biotech High And Sustainable

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

2 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$49.65

-2.6%

4.3%

TTY Biopharm

Market Cap: NT$18.5b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$74.40

-3.4%

-2.7%